The Samuel Roberts Noble Foundation has made a gift of $6 million to the Oklahoma Medical Research Foundation, the two foundations announced today. The gift, to be paid out in three annual installments of $2 million through 2010, will go toward construction of a new research tower at OMRF. That construction is expected to begin […]
News
OMRF scientist finds genetic link between X chromosome and lupus
Scientists have long known that the autoimmune disease lupus disproportionately strikes women. And though they have searched for a genetic link between the disease and the X chromosome—women carry two, while men carry only one—they’ve not found one. Until now. Oklahoma Medical Research Foundation scientist Amr Sawalha, M.D., has discovered an association between a gene […]
Sepsis survivor thanks OMRF scientists who saved her
Rayna DuBose came to say thank you. And thank you and thank you and thank you. “OMRF, the scientists and doctors—it’s good to meet the people who helped save me,” she said. “I just wanted to say thank you. I can’t say it enough.” DuBose, a 24-year-old Virginian, spoke Tuesday to more than 100 Oklahoma […]
Stealing Science: OMRF scientist helps craft anti-plagiarism tool
Much like the world of college essays, scientific journals are often plagued with authors trying to publish someone else’s work as their own. For Oklahoma Medical Research Foundation scientist Jonathan Wren, Ph.D., the issue hit home as part of his duties as an editor for the journal Bioinformatics, when a reviewer recognized a paper as […]
ALEXION ACQUIRES ALL RIGHTS TO OMRF PATENTS RELATED TO SOLIRIS®
The Oklahoma Medical Research Foundation (“OMRF”) and Alexion Pharmaceuticals, Inc. (“Alexion,” Nasdaq: ALXN) today announced that Alexion has agreed to acquire from OMRF all rights to certain patents related to complement-inhibition technology. Background The patents cover inventions made by OMRF in the 1980s relating to the treatment of complement system mediated disorders, to which Alexion […]
OMRF discovers potential Huntington’s treatment
Scientists at the Oklahoma Medical Research Foundation have identified a compound that shows promise in treating Huntington’s disease. They are now performing pre-clinical tests to assess whether the chemical slows the progress of the deadly disease of the nervous system. Led by Kenneth Hensley, Ph.D., OMRF researchers are performing pre-clinical tests using lanthionine ketimine (LK), […]
